Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary allogeneic mesenchymal precursor cells for ST-elevation myocardial infarction
2010-020497-41Phase 2Unknown
- Sponsor
- Mesoblast Ltd
- Start
- Aug 2011
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute ST-segment elevation myocardial infarction (STEMI) comparing Allogeneic mesenchymal precursor cells with Placebo (2 arms). Primary endpoints: Feasibility of investigational agent infusion and Safety and feasibility. Status: unknown.
02
Drugs
rexlemestrocel-l
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on 2010-020497-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020497-41.